144 related articles for article (PubMed ID: 31391026)
1. Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer.
Xiao Y; Lu J; Chang W; Chen Y; Li X; Li D; Xu C; Yang H
BMC Cancer; 2019 Aug; 19(1):785. PubMed ID: 31391026
[TBL] [Abstract][Full Text] [Related]
2. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
3. Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer.
Xiao Y; Yang H; Lu J; Li D; Xu C; Risch HA
BMC Cancer; 2019 Oct; 19(1):1020. PubMed ID: 31664937
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients.
Xiao Y; Chen W; Xie Z; Shao Z; Xie H; Qin G; Zhao N
BMC Cancer; 2017 Jan; 17(1):25. PubMed ID: 28056913
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma.
Ji F; Fu SJ; Guo ZY; Pang H; Ju WQ; Wang DP; Hua YP; He XS
Medicine (Baltimore); 2016 Jul; 95(27):e4065. PubMed ID: 27399091
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
7. Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients.
Hung HY; Chen JS; Chien-YuhYeh ; Tang R; Hsieh PS; Wen-SyTasi ; You YT; You JF; Chiang JM
Int J Colorectal Dis; 2017 Dec; 32(12):1775-1778. PubMed ID: 29030683
[TBL] [Abstract][Full Text] [Related]
8. Serum Alkaline Phosphatase, Phosphate, and In-Hospital Mortality in Acute Ischemic Stroke Patients.
Zhong C; You S; Chen J; Zhai G; Du H; Luo Y; Dong X; Cao Y; Liu CF; Zhang Y
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):257-266. PubMed ID: 28986200
[TBL] [Abstract][Full Text] [Related]
9. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR
JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217
[TBL] [Abstract][Full Text] [Related]
10. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
11. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
12. Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.
Ben-Josef E; George A; Regine WF; Abrams R; Morgan M; Thomas D; Schaefer PL; DiPetrillo TA; Fromm M; Small W; Narayan S; Winter K; Griffith KA; Guha C; Williams TM
Clin Cancer Res; 2015 Dec; 21(24):5612-8. PubMed ID: 26240274
[TBL] [Abstract][Full Text] [Related]
13. Survivin expression and serum levels in pancreatic cancer.
Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer.
Rasmussen LS; Yilmaz MK; Falkmer UG; Poulsen LØ; Bøgsted M; Christensen HS; Bojesen SE; Jensen BV; Chen IM; Johansen AZ; Hansen CP; Hasselby JP; Holländer N; Nielsen SE; Andersen F; Bjerregaard JK; Pfeiffer P; Johansen JS
Eur J Cancer; 2021 Feb; 144():72-80. PubMed ID: 33341448
[TBL] [Abstract][Full Text] [Related]
15. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma.
Tessier-Cloutier B; Kalloger SE; Al-Kandari M; Milne K; Gao D; Nelson BH; Renouf DJ; Sheffield BS; Schaeffer DF
BMC Cancer; 2017 Sep; 17(1):618. PubMed ID: 28870260
[TBL] [Abstract][Full Text] [Related]
17. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Lembeck AL; Posch F; Klocker EV; Szkandera J; Schlick K; Stojakovic T; Kornprat P; Lackner C; Gerger A; Stoeger H; Stotz M; Pichler M
Clin Chem Lab Med; 2019 Apr; 57(5):740-744. PubMed ID: 30307891
[TBL] [Abstract][Full Text] [Related]
18. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
[TBL] [Abstract][Full Text] [Related]
20. Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma.
Antwi SO; Bamlet WR; Cawthon RM; Rabe KG; Druliner BR; Sicotte H; Jatoi A; Mahipal A; Boardman LA; Oberg AL; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):210-216. PubMed ID: 33187969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
